Keithi-Reddy Sai Ram R, Chakravarthi Rajasekhara M, Hussaini Shaista M, Venkatapuram Rohini R, Murthy J M K
Renal division, Brigham & Women's Hospital, 1620, Tremont street, 3rd floor, Boston, MA 02120, USA.
Int Urol Nephrol. 2007;39(3):967-70. doi: 10.1007/s11255-007-9197-7. Epub 2007 Apr 21.
Anecdotal reports of acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) with cytomegalovirus (CMV) suggested as the etiological agent have been described in transplant recipients with poor prognosis. We describe a 48-year-old man, a cadaveric renal allograft recipient on cyclosporine, mycophenolate mofetil and prednisolone, who developed febrile illness with unexplained anemia followed by progressive weakness of the upper and lower limbs. He was diagnosed as a case of Guillain-Barré syndrome (GBS). His CMV serology was positive by polymerase chain reaction (PCR). We treated him with both gancyclovir and intravenous immunoglobulins within a week of the onset of GBS and observed rapid recovery. Thus, search for CMV is warranted in transplant patients presenting with GBS, as early initiation of treatment with gancyclovir and immunoglobulins can help expedite recovery.
有报道称,移植受者中出现以巨细胞病毒(CMV)为病因的急性炎症性脱髓鞘性多发性神经病(吉兰-巴雷综合征),预后较差。我们描述了一名48岁男性,他是一名接受尸体肾移植的患者,正在使用环孢素、霉酚酸酯和泼尼松龙治疗,出现了发热性疾病并伴有不明原因的贫血,随后出现上下肢进行性无力。他被诊断为吉兰-巴雷综合征(GBS)。通过聚合酶链反应(PCR)检测,他的CMV血清学呈阳性。在GBS发病一周内,我们用更昔洛韦和静脉注射免疫球蛋白对他进行了治疗,观察到他迅速康复。因此,对于出现GBS的移植患者,有必要进行CMV检测,因为早期开始使用更昔洛韦和免疫球蛋白治疗有助于加快康复。